Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Đang chuẩn bị liên kết để tải về tài liệu:
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Khánh Linh 74 7 pdf

Premature discontinuation of aromatase inhibitors (AIs) in breast cancer survivors compromises treatment outcomes. We aimed to evaluate whether patient-reported joint pain predicts premature discontinuation of AIs. |

Đang chuẩn bị liên kết để tải về tài liệu:
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Premature discontinuation of aromatase inhibitors (AIs) in breast cancer survivors compromises treatment outcomes. We aimed to evaluate whether patient-reported joint pain predicts premature discontinuation of AIs. |

Generalized joint hypermobility in childhood is a possible risk for the development of joint pain in adolescence: A cohort study

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Technical variation of trans-articular sacroiliac joint (SIJ) fusion using three screws considering the effects of sacral dysplasia in patients with non-traumatic SIJ pain

Pelvic joint fusion in patients with severe pelvic girdle pain – a prospective single-subject research design study

Lectures Musculoskeletal Care for the General Doctor: Shoulder and Knee Pain - C. Christopher Smith, MD

The Association of Self-Reported Generalized Joint Hypermobility with pelvic girdle pain during pregnancy: A retrospective cohort study

A combination of Tamarindus indica seeds and Curcuma longa rhizome extracts improves knee joint function and alleviates pain in non-arthritic adults following physical activity

Self-perceived weather sensitivity and joint pain in older people with osteoarthritis in six European countries: Results from the European Project on OSteoArthritis (EPOSA)

Arthralgias, fatigue, paresthesias and visceral pain: Can joint hypermobility solve the puzzle? A case report

The clinical characteristics of older people with chronic multiple-site joint pains and their utilisation of therapeutic interventions: Data from a prospective cohort study

Đang chuẩn bị liên kết để tải về tài liệu: Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Premature discontinuation of aromatase inhibitors (AIs) in breast cancer survivors compromises treatment outcomes. We aimed to evaluate whether patient-reported joint pain predicts premature discontinuation of AIs. |

Generalized joint hypermobility in childhood is a possible risk for the development of joint pain in adolescence: A cohort study

Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors

Technical variation of trans-articular sacroiliac joint (SIJ) fusion using three screws considering the effects of sacral dysplasia in patients with non-traumatic SIJ pain

Pelvic joint fusion in patients with severe pelvic girdle pain – a prospective single-subject research design study

Lectures Musculoskeletal Care for the General Doctor: Shoulder and Knee Pain - C. Christopher Smith, MD

The Association of Self-Reported Generalized Joint Hypermobility with pelvic girdle pain during pregnancy: A retrospective cohort study

A combination of Tamarindus indica seeds and Curcuma longa rhizome extracts improves knee joint function and alleviates pain in non-arthritic adults following physical activity

Self-perceived weather sensitivity and joint pain in older people with osteoarthritis in six European countries: Results from the European Project on OSteoArthritis (EPOSA)

Arthralgias, fatigue, paresthesias and visceral pain: Can joint hypermobility solve the puzzle? A case report

The clinical characteristics of older people with chronic multiple-site joint pains and their utilisation of therapeutic interventions: Data from a prospective cohort study

Đang chuẩn bị liên kết để tải về tài liệu:
Joint pain severity predicts premature discontinuation of aromatase inhibitors in breast cancer survivors